Exagen Inc. (XGN) Tops Q3 EPS by 1c

Exagen Inc. (NASDAQ: XGN) reported Q3 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.57 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Battery X Metals adds auto industry advisor to board